BioCentury | Aug 1, 2011
Clinical News

TK54 regulatory update

...The European Commission granted Orphan Drug designation for LTKfarma's TK54 to treat acute lymphoblastic leukemia (ALL...
...in the EU to treat acute myelogenous leukemia (AML). LTKfarma S.A.S. , Evry, France Product: TK54...
BioCentury | Oct 25, 2010
Clinical News

TK54 regulatory update

...The European Commission granted Orphan Drug designation for LTKfarma's TK54 to treat acute myelogenous leukemia (AML...
...allogeneic T cells encoding an exogenous thymidine kinase gene. LTKfarma S.A.S. , Evry, France Product: TK54...
Items per page:
1 - 2 of 2